Café

© 2026 Longbridge｜Terms of Service Privacy Policy

MBBEONE@EC2608A

26100

0.0100.00% ( 0.000 )

Delay Closed: Aug 20, 16:08:00

OverviewOverview NewsNews PostsPosts

LongbridgeAI

HK Midday: HSI up 1.22%; Innovator Drug Stocks Surge, Everest Medicines Soars Nearly 60%
Market Pulse·11 hours ago
- Hong Kong stocks maintained an upward trend on August 20, with the Hang Seng Index rising 1.22% to 25807.29 points. - The innovative drug sector surged significantly driven by Moderna mRNA vaccine developments and strong interim results, while gold stocks strengthened as spot gold broke 4500 USD. - Meanwhile, internet technology stocks showed divergence, highlighted by Kuaishou dropping over 10% following weaker-than-expected financial results.
01952+41.43%01177+12.53%
HSI Up 291 pts; HSTI Up 72 pts; XIAOMI Up over 3%; WUXI BIO, WUXI APPTEC, BEIGENE, OOIL, TINGYI Hit New Highs
AASTOCKS News·13 hours ago
- At the midday close, the Hang Seng Index rose 291 points to reach 25,786, while the Hang Seng Tech Index increased by 72 points to 4,754. - Major heavyweights such as XIAOMI, BABA, and TENCENT recorded solid gains alongside broader market movements. - Stocks including WUXI BIO, WUXI APPTEC, BEIGENE, OOIL, and TINGYI hit new highs during the trading session.
WXXWY+1.87%BGNE0.00%
BeOne Medicines and partners renew Brukinsa access programme for CLL
Pharmaceutical Technology·1 day ago, 02:49 AM
BGNE0.00%ONC-1.09%
Hong Kong Micro-Fundamentals Diverge as AI Hardware Booms and Biotech Faces Earnings Reality Check
Global Report·2 days ago, 05:12 AM
02577+3.06%03887+7.69%
HK Stocks Midday: HSI Falls Over 100 Pts; Oil Stocks Rise on Mideast Tensions; Biotech Broadly Higher
Market Pulse·2 days ago, 09:19 PM
- On August 18 morning, Hong Kong stock indices declined collectively, with the Hang Seng Index down 0.58 % to 25305 points. - Oil and biotech stocks bucked the trend to rise, driven by escalating Middle East tensions and strong domestic pharmaceutical export trade values. - Financial, insurance, and major technology stocks faced downward pressure amid rising 30-year US Treasury yields and overseas debt reductions.
02269+3.63%06160+1.88%
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries | ONC Stock News
StockTitan·2 days ago, 09:00 PM
BGNE0.00%ONC-1.09%
BeiGene gains 2% in Hong Kong after sharp intraday surge
HK Stock Market Update·2 days ago, 08:41 PM
06160+1.88%
Daiwa Reaffirms Their Buy Rating on BeOne Medicines Ltd (6160)
Tip Ranks·Aug 14 at 04:15 AM
BGNE0.00%06160+1.88%
BeOne Medicines CEO John Oyler sells USD 67.94 million in ADSs (common shares)
PUBT·Aug 12 at 04:54 PM
BGNE0.00%ONC-1.09%
HK Equities Earnings Diverge as BeiGene Surges While Cement Makers Issue Profit Warnings
Global Report·Aug 11 at 05:13 AM
06160+1.88%06060-3.93%
Inside the Hong Kong Biotech Rebound: BeiGene's Blockbuster Earnings and Venus Medtech's New Lifeline
Global Report·Aug 11 at 04:42 AM
06160+1.88%02500+7.77%
HK Midday: Hang Seng Drops Nearly 1%, Loses 26,000; Biomed Stocks Surge, Autos Tumble
Market Pulse·Aug 11 at 01:29 AM
- On August 11, Hong Kong stocks fluctuated weakly, with the Hang Seng Index falling 0.93% to 25697.35 points. - Biopharmaceutical and oil stocks strengthened against the market trend driven by positive catalysts and rising oil prices. - Technology and auto stocks generally declined amid market wait-and-see sentiment, high inventory pressures, and upcoming earnings and inflation data.
03759+7.70%02142+12.49%
BeiGene climbs 4% in Hong Kong trading after RAS collaboration deal
HK Stock Market Update·Aug 10 at 08:34 PM
06160+1.88%
BOCOM International Holdings Company Keeps Their Buy Rating on BeOne Medicines Ltd (6160)
Tip Ranks·Aug 9 at 09:35 AM
BGNE0.00%06160+1.88%
BeOne Medicines Ltd (6160) Gets a Buy from CICC
Tip Ranks·Aug 7 at 07:35 PM
BGNE0.00%06160+1.88%